A Pilot Study on Efficacy and Safety of Ayurveda Combination in Patients With Mild-to-Moderate COVID-19

Inclusion Criteria: * With SARS-CoV-2 infection confirmed through reverse transcription followed by polymerase chain reaction (RT- PCR), * With mild or moderate manifestations of COVID-19 * Willing to participate, and consent by signing the informed consent and not involved in another clinical trial during the study period Exclusion Criteria: * Patients suffering from severe COVID-19 Disease as judged by WHO criteria (REF) * Any of the known COVID-19 complications and emergency procedures which may require shift/admission in hospital for oxygen support or intensive care unit * Patients with ongoing immunosuppressive therapy for any reasons for example solid organ transplantation, autoimmune diseases or cancer. * Patients with known long term infection like HIV * Active cancer diagnosis, on palliative treatment or requiring current therapy with antimetabolic agents, immunotherapy or radiotherapy. * Pregnancy and lactation * Ayurveda practitioner decision that involvement in the study is not in the patient's best interest